222 related articles for article (PubMed ID: 34638902)
1. Lipidomic and Proteomic Alterations Induced by Even and Odd Medium-Chain Fatty Acids on Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.
Alatibi KI; Tholen S; Wehbe Z; Hagenbuchner J; Karall D; Ausserlechner MJ; Schilling O; Grünert SC; Vockley J; Tucci S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638902
[TBL] [Abstract][Full Text] [Related]
2. Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.
Alatibi KI; Hagenbuchner J; Wehbe Z; Karall D; Ausserlechner MJ; Vockley J; Spiekerkoetter U; Grünert SC; Tucci S
Cells; 2021 May; 10(5):. PubMed ID: 34069977
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific perturbation of complex lipids in response to medium-chain fatty acids in very long-chain acyl-CoA dehydrogenase deficiency.
Alatibi KI; Wehbe Z; Spiekerkoetter U; Tucci S
FEBS J; 2020 Aug; 287(16):3511-3525. PubMed ID: 31971349
[TBL] [Abstract][Full Text] [Related]
4. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
Tucci S; Behringer S; Spiekerkoetter U
FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
[TBL] [Abstract][Full Text] [Related]
5. Effects of odd-numbered medium-chain fatty acids on the accumulation of long-chain 3-hydroxy-fatty acids in long-chain L-3-hydroxyacyl CoA dehydrogenase and mitochondrial trifunctional protein deficient skin fibroblasts.
Jones PM; Butt YM; Bennett MJ
Mol Genet Metab; 2004 Feb; 81(2):96-9. PubMed ID: 14741189
[TBL] [Abstract][Full Text] [Related]
6. Unique plasma metabolomic signatures of individuals with inherited disorders of long-chain fatty acid oxidation.
McCoin CS; Piccolo BD; Knotts TA; Matern D; Vockley J; Gillingham MB; Adams SH
J Inherit Metab Dis; 2016 May; 39(3):399-408. PubMed ID: 26907176
[TBL] [Abstract][Full Text] [Related]
7. The fate of medium-chain fatty acids in very long-chain acyl‑CoA dehydrogenase deficiency (VLCADD): A matter of sex?
Wehbe Z; Alatibi K; Jellusova J; Spiekerkoetter U; Tucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1591-1605. PubMed ID: 31394165
[TBL] [Abstract][Full Text] [Related]
8. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
Jones PM; Butt Y; Bennett MJ
Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
[TBL] [Abstract][Full Text] [Related]
10. Odd- and even-numbered medium-chained fatty acids protect against glutathione depletion in very long-chain acyl-CoA dehydrogenase deficiency.
Lund M; Heaton R; Hargreaves IP; Gregersen N; Olsen RKJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Feb; 1868(2):159248. PubMed ID: 36356723
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
12. Proposal for an individualized dietary strategy in patients with very long-chain acyl-CoA dehydrogenase deficiency.
Bleeker JC; Kok IL; Ferdinandusse S; de Vries M; Derks TGJ; Mulder MF; Williams M; Gozalbo ER; Bosch AM; van den Hurk DT; de Sain-van der Velden MGM; Waterham HR; Wijburg FA; Visser G
J Inherit Metab Dis; 2019 Jan; 42(1):159-168. PubMed ID: 30740737
[TBL] [Abstract][Full Text] [Related]
13. Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts.
Rhead WJ; Amendt BA; Fritchman KS; Felts SJ
Science; 1983 Jul; 221(4605):73-5. PubMed ID: 6857268
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
[TBL] [Abstract][Full Text] [Related]
15. Tracer-based lipidomics enables the discovery of disease-specific candidate biomarkers in mitochondrial β-oxidation disorders.
Schwantje M; Mosegaard S; Knottnerus SJG; van Klinken JB; Wanders RJ; van Lenthe H; Hermans J; IJlst L; Denis SW; Jaspers YRJ; Fuchs SA; Houtkooper RH; Ferdinandusse S; Vaz FM
FASEB J; 2024 Feb; 38(4):e23478. PubMed ID: 38372965
[TBL] [Abstract][Full Text] [Related]
16. The effect of valinomycin in fibroblasts from patients with fatty acid oxidation disorders.
Ndukwe Erlingsson UC; Iacobazzi F; Liu A; Ardon O; Pasquali M; Longo N
Biochem Biophys Res Commun; 2013 Aug; 437(4):637-41. PubMed ID: 23867825
[TBL] [Abstract][Full Text] [Related]
17. Heptanoate Improves Compensatory Mechanism of Glucose Homeostasis in Mitochondrial Long-Chain Fatty Acid Oxidation Defect.
Nurjanah S; Gerding A; Vieira-Lara MA; Evers B; Langelaar-Makkinje M; Spiekerkoetter U; Bakker BM; Tucci S
Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960342
[TBL] [Abstract][Full Text] [Related]
18. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
[TBL] [Abstract][Full Text] [Related]
19. An Altered Sphingolipid Profile as a Risk Factor for Progressive Neurodegeneration in Long-Chain 3-Hydroxyacyl-CoA Deficiency (LCHADD).
Tucci S
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806149
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride.
Roe CR; Sweetman L; Roe DS; David F; Brunengraber H
J Clin Invest; 2002 Jul; 110(2):259-69. PubMed ID: 12122118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
